About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Migraine Clinical Trials in San Antonio | 9 Studies

Clinical Trials MigraineSan Antonio

Migraine Clinical Trials in San Antonio

Find 9 clinical trials for migraine near San Antonio, Texas. Connect with research centers in your area.

All Migraine trials nationwide All trials in San Antonio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-9 of 9 trials

Active not recruitingA Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in AdultsThe purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing chronic migraine.NCT06047444·Birmingham, Alabama and 119 others

Migraine Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Study of Eptinezumab in Pediatric Participants With Episodic MigraineThe main goal of this trial is to learn whether eptinezumab helps reduce the number of days with episodic migraine in pediatric participants.NCT05897320·Stamford, Connecticut and 61 others

CompletedEfficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine PreventionThis study will evaluate the safety and tolerability of the following doses of atogepant (AGN-241689): 10 mg once daily (QD), 30 mg QD, 30 mg twice daily (BID), 60 mg QD, and 60…NCT02848326·Birmingham, Alabama and 74 others

Not yet recruitingA Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of MigraineThis is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep, as compared with placebo, in the treatment of moderate or severe…NCT07816367·Glendale, Arizona and 71 others

CompletedAn Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of MigraineThis is a prospective, randomized, open-label study in subjects with migraine who have completed the Phase 3 studies, COL MIG 301/LAHJ (NCT02439320) or COL MIG-302/LAHK…NCT02565186·Birmingham, Alabama and 195 others

CompletedStudy of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With MigraineA migraine attack is a moderate or severe headache that usually occurs on one side of the head and is often accompanied by throbbing, sensitivity to light, sensitivity to sound…NCT06241313·Edegem, Antwerpen and 148 others

Active not recruitingA Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic MigraineThe main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatment of episodic migraine.NCT03432286·Huntsville, Alabama and 72 others

CompletedStudy of Sustained Benefit of AMG334 in Adult Episodic Migraine PatientsThe purpose of this study is to compare the sustained long-term benefit between two treatment paradigms of migraine prophylactic agents (erenumab versus a control arm of oral…NCT03927144·Stanford, California and 111 others

CompletedEvaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 StudyThe main purpose of this study is to evaluate the efficacy of the study drug known as galcanezumab in participants with episodic migraine.NCT02614183·Tucson, Arizona and 94 others

Other Conditions in San Antonio

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia